← Back to Search

Behavioural Intervention

Parenting Intervention for Substance Use Disorder

N/A
Waitlist Available
Led By Mei Elansary, MD MPhil
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mothers must be English speaking
Mothers must be 18 years of age or older
Must not have
Mothers must not have severe cognitive limitations or medical or psychiatric conditions that limit their capacity to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial aims to evaluate a brief parent-child interaction therapy called THRIVE, which will be offered at the SOFAR Clinic in Boston. The therapy is conducted over 6 telehealth sessions and has

Who is the study for?
This trial is for mothers with substance use disorder who have children affected by their condition. It's designed to help them cope with the stress of parenthood and improve child development through a program called SOFAR, which offers integrated behavioral health support.
What is being tested?
The intervention being tested is THRIVE, a brief telehealth parenting program based on parent-child interaction therapy. The study will evaluate its implementation in the SOFAR Clinic and aims to see if it can improve child behaviors and reduce parenting stress.
What are the potential side effects?
Since THRIVE is a non-medical, therapeutic intervention focusing on improving parenting skills via telehealth sessions, there are no direct medical side effects associated with drugs or procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a mother and I speak English.
Select...
I am a mother and I am 18 years old or older.
Select...
I am the main person taking care of my child.
Select...
My child is between 3 and 6 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am mentally capable of understanding and consenting to medical procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of the THRIVE intervention
Duration of THRIVE intervention sessions
Feasibility of the THRIVE intervention based on enrollment
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Threat, harm, risk, investigation, vulnerability and engagement (THRIVE) interventionExperimental Treatment1 Intervention
The THRIVE intervention will be offered by a trained therapist to participants (mother-child dyads) in the SOFAR Clinic.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
THRIVE
2017
N/A
~560

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
395 Previous Clinical Trials
875,479 Total Patients Enrolled
Washington University School of MedicineOTHER
1,970 Previous Clinical Trials
2,308,573 Total Patients Enrolled
Mei Elansary, MD MPhilPrincipal InvestigatorBoston Medical Center, Pediatrics
~33 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top